{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:00:53Z","timestamp":1790654453958,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-025-01070-8","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:52:11Z","timestamp":1739559131000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["LmCen\u2212\/\u2212 based vaccine is protective against canine visceral leishmaniasis following three natural exposures in Tunisia"],"prefix":"10.1038","volume":"10","author":[{"given":"Thouraya","family":"Boussoffara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imen","family":"Labidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malek","family":"Trim\u00e8che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifhem","family":"Chelbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Dachraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nourhane","family":"Msallem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abdo Saghir Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifedine","family":"Cherni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamaleshwar P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarnendu","family":"Kaviraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0069-7867","authenticated-orcid":false,"given":"Ranadhir","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Varikuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-8220","authenticated-orcid":false,"given":"Sreenivas","family":"Gannavaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais","family":"da S. Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1996-876X","authenticated-orcid":false,"given":"Wen-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5550-712X","authenticated-orcid":false,"given":"Patrick","family":"Lypaczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3881-8337","authenticated-orcid":false,"given":"Shinjiro","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotomo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hechmi","family":"Louzir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-1620","authenticated-orcid":false,"given":"Hira L.","family":"Nakhasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5989-1520","authenticated-orcid":false,"given":"Abhay R.","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-5525","authenticated-orcid":false,"given":"Greg","family":"Matlashewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyes","family":"Zhioua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"1070_CR1","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3390\/microorganisms10101887","volume":"10","author":"S Scarpini","year":"2022","unstructured":"Scarpini, S. et al. Visceral leishmaniasis: epidemiology, diagnosis, and treatment regimens in different geographical areas with a focus on pediatrics. Microorganisms 10, 1887 (2022).","journal-title":"Microorganisms"},{"key":"1070_CR2","unstructured":"(WHO), W.H.O. Leishmaniasis. 2022 [cited] Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis."},{"key":"1070_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1017\/S0950268806006881","volume":"135","author":"GL Werneck","year":"2007","unstructured":"Werneck, G. L. et al. Multilevel modelling of the incidence of visceral leishmaniasis in Teresina, Brazil. Epidemiol. Infect. 135, 195\u2013201 (2007).","journal-title":"Epidemiol. Infect."},{"key":"1070_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-308X(04)57001-X","volume":"57","author":"J Alvar","year":"2004","unstructured":"Alvar, J., Canavate, C., Molina, R., Moreno, J. & Nieto, J. Canine leishmaniasis. Adv. Parasitol. 57, 1\u201388 (2004).","journal-title":"Adv. Parasitol."},{"key":"1070_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/0300985814521248","volume":"51","author":"AF Koutinas","year":"2014","unstructured":"Koutinas, A. F. & Koutinas, C. K. Pathologic mechanisms underlying the clinical findings in canine leishmaniasis due to Leishmania infantum\/chagasi. Vet. Pathol. 51, 527\u2013538 (2014).","journal-title":"Vet. Pathol."},{"key":"1070_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/vetsci9080387","volume":"9","author":"M Morales-Yuste","year":"2022","unstructured":"Morales-Yuste, M., Martin-Sanchez, J. & Corpas-Lopez, V. Canine Leishmaniasis: Update on Epidemiology, Diagnosis, Treatment, and Prevention. Vet. Sci. 9, 387 (2022).","journal-title":"Vet. Sci."},{"key":"1070_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/bs.apar.2016.08.001","volume":"94","author":"KS Rock","year":"2016","unstructured":"Rock, K. S., Quinnell, R. J., Medley, G. F. & Courtenay, O. Progress in the Mathematical Modelling of Visceral Leishmaniasis. Adv. Parasitol. 94, 49\u2013131 (2016).","journal-title":"Adv. Parasitol."},{"key":"1070_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","volume":"55","author":"C Dye","year":"1996","unstructured":"Dye, C. The logic of visceral leishmaniasis control. Am. J. Trop. Med Hyg. 55, 125\u2013130 (1996).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"1070_CR9","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1016\/j.vaccine.2005.02.015","volume":"23","author":"A Khamesipour","year":"2005","unstructured":"Khamesipour, A. et al. Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis. Vaccine 23, 3642\u20133648 (2005).","journal-title":"Vaccine"},{"key":"1070_CR10","doi-asserted-by":"publisher","first-page":"25703","DOI":"10.1074\/jbc.M402794200","volume":"279","author":"A Selvapandiyan","year":"2004","unstructured":"Selvapandiyan, A. et al. Centrin gene disruption impairs stage-specific basal body duplication and cell cycle progression in Leishmania. J. Biol. Chem. 279, 25703\u201325710 (2004).","journal-title":"J. Biol. Chem."},{"key":"1070_CR11","doi-asserted-by":"publisher","first-page":"43253","DOI":"10.1074\/jbc.M106806200","volume":"276","author":"A Selvapandiyan","year":"2001","unstructured":"Selvapandiyan, A. et al. Expression of a mutant form of Leishmania donovani centrin reduces the growth of the parasite. J. Biol. Chem. 276, 43253\u201343261 (2001).","journal-title":"J. Biol. Chem."},{"key":"1070_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17154-z","volume":"11","author":"WW Zhang","year":"2020","unstructured":"Zhang, W. W. et al. A second generation leishmanization vaccine with a markerless attenuated Leishmania major strain using CRISPR gene editing. Nat. Commun. 11, 3461 (2020).","journal-title":"Nat. Commun."},{"key":"1070_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s42003-021-02446-x","volume":"4","author":"S Karmakar","year":"2021","unstructured":"Karmakar, S. et al. Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis. Commun. Biol. 4, 929 (2021).","journal-title":"Commun. Biol."},{"key":"1070_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.vaccine.2013.01.048","volume":"31","author":"JA Fiuza","year":"2013","unstructured":"Fiuza, J. A. et al. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs. Vaccine 31, 1785\u20131792 (2013).","journal-title":"Vaccine"},{"key":"1070_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.vaccine.2014.11.039","volume":"33","author":"JA Fiuza","year":"2015","unstructured":"Fiuza, J. A. et al. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum. Vaccine 33, 280\u2013288 (2015).","journal-title":"Vaccine"},{"key":"1070_CR16","doi-asserted-by":"publisher","first-page":"e1000484","DOI":"10.1371\/journal.ppat.1000484","volume":"5","author":"NC Peters","year":"2009","unstructured":"Peters, N. C. et al. Vector transmission of leishmania abrogates vaccine-induced protective immunity. PLoS Pathog. 5, e1000484 (2009).","journal-title":"PLoS Pathog."},{"key":"1070_CR17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.pt.2021.07.003","volume":"37","author":"TD Serafim","year":"2021","unstructured":"Serafim, T. D. et al. Leishmaniasis: the act of transmission. Trends Parasitol. 37, 976\u2013987 (2021).","journal-title":"Trends Parasitol."},{"key":"1070_CR18","unstructured":"Magill, A. J., Ryan, E. T., Hill, D. R. & Solomon, T. Hunter\u2019s Tropical Medicine and Emerging Infectious Disease, 9, illustrated edn. Elsevier Health Sciences, 2012, (2012)."},{"key":"1070_CR19","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","volume":"27","author":"CB Palatnik-de-Sousa","year":"2009","unstructured":"Palatnik-de-Sousa, C. B. et al. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas. Vaccine 27, 3505\u20133512 (2009).","journal-title":"Vaccine"},{"key":"1070_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.1700674","volume":"200","author":"A Banerjee","year":"2018","unstructured":"Banerjee, A. et al. Live Attenuated Leishmania donovani Centrin Gene-Deleted Parasites Induce IL-23-Dependent IL-17-Protective Immune Response against Visceral Leishmaniasis in a Murine Model. J. Immunol. 200, 163\u2013176 (2018).","journal-title":"J. Immunol."},{"key":"1070_CR21","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.4049\/jimmunol.1500752","volume":"195","author":"A Romano","year":"2015","unstructured":"Romano, A., Doria, N. A., Mendez, J., Sacks, D. L. & Peters, N. C. Cutaneous Infection with Leishmania major Mediates Heterologous Protection against Visceral Infection with Leishmania infantum. J. Immunol. 195, 3816\u20133827 (2015).","journal-title":"J. Immunol."},{"key":"1070_CR22","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.4049\/jimmunol.1303145","volume":"193","author":"R Dey","year":"2014","unstructured":"Dey, R. et al. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana. J. Immunol. 193, 3513\u20133527 (2014).","journal-title":"J. Immunol."},{"key":"1070_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-022-00574-x","volume":"7","author":"S Karmakar","year":"2022","unstructured":"Karmakar, S. et al. Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis. NPJ Vaccines 7, 157 (2022).","journal-title":"NPJ Vaccines"},{"key":"1070_CR24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.3390\/vaccines8040690","volume":"8","author":"RDO Aguiar-Soares","year":"2020","unstructured":"Aguiar-Soares, R. D. O. et al. Phase I and II Clinical Trial Comparing the LBSap, Leishmune((R)), and Leish-Tec((R)) Vaccines against Canine Visceral Leishmaniasis. Vaccines (Basel) 8, 690 (2020).","journal-title":"Vaccines (Basel)"},{"key":"1070_CR25","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1086\/344733","volume":"186","author":"RB Gomes","year":"2002","unstructured":"Gomes, R. B. et al. Seroconversion against Lutzomyia longipalpis saliva concurrent with the development of anti-Leishmania chagasi delayed-type hypersensitivity. J. Infect. Dis. 186, 1530\u20131534 (2002).","journal-title":"J. Infect. Dis."},{"key":"1070_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pt.2008.04.001","volume":"24","author":"G Baneth","year":"2008","unstructured":"Baneth, G., Koutinas, A. F., Solano-Gallego, L., Bourdeau, P. & Ferrer, L. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part one. Trends Parasitol. 24, 324\u2013330 (2008).","journal-title":"Trends Parasitol."},{"key":"1070_CR27","doi-asserted-by":"publisher","first-page":"892817","DOI":"10.1155\/2012\/892817","volume":"2012","author":"KJ Evans","year":"2012","unstructured":"Evans, K. J. & Kedzierski, L. Development of Vaccines against Visceral Leishmaniasis. J. Trop. Med. 2012, 892817 (2012).","journal-title":"J. Trop. Med."},{"key":"1070_CR28","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/tmi.13382","volume":"25","author":"R Velez","year":"2020","unstructured":"Velez, R. & Gallego, M. Commercially approved vaccines for canine leishmaniosis: a review of available data on their safety and efficacy. Trop. Med Int Health 25, 540\u2013557 (2020).","journal-title":"Trop. Med Int Health"},{"key":"1070_CR29","doi-asserted-by":"publisher","first-page":"e0185438","DOI":"10.1371\/journal.pone.0185438","volume":"12","author":"G Grimaldi Jr.","year":"2017","unstructured":"Grimaldi, G. Jr. et al. Field trial of efficacy of the Leish-tec(R) vaccine against canine leishmaniasis caused by Leishmania infantum in an endemic area with high transmission rates. PLoS ONE 12, e0185438 (2017).","journal-title":"PLoS ONE"},{"key":"1070_CR30","doi-asserted-by":"publisher","first-page":"e3213","DOI":"10.1371\/journal.pntd.0003213","volume":"8","author":"G Oliva","year":"2014","unstructured":"Oliva, G. et al. A randomised, double-blind, controlled efficacy trial of the LiESP\/QA-21 vaccine in naive dogs exposed to two leishmania infantum transmission seasons. PLoS Negl. Trop. Dis. 8, e3213 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1070_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.vetimm.2008.10.307","volume":"128","author":"AB Reis","year":"2009","unstructured":"Reis, A. B. et al. Systemic and compartmentalized immune response in canine visceral leishmaniasis. Vet. Immunol. Immunopathol. 128, 87\u201395 (2009).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"1070_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fcimb.2018.00302","volume":"8","author":"C Maia","year":"2018","unstructured":"Maia, C. & Campino, L. Biomarkers Associated With Leishmania infantum Exposure, Infection, and Disease in Dogs. Front Cell Infect. Microbiol 8, 302 (2018).","journal-title":"Front Cell Infect. Microbiol"},{"key":"1070_CR33","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.vaccine.2016.03.019","volume":"34","author":"S Regina-Silva","year":"2016","unstructured":"Regina-Silva, S. et al. Field randomized trial to evaluate the efficacy of the Leish-Tec(R) vaccine against canine visceral leishmaniasis in an endemic area of Brazil. Vaccine 34, 2233\u20132239 (2016).","journal-title":"Vaccine"},{"key":"1070_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4269\/ajtmh.2001.64.119","volume":"64","author":"BL Travi","year":"2001","unstructured":"Travi, B. L., Tabares, C. J., Cadena, H., Ferro, C. & Osorio, Y. Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies. Am. J. Trop. Med Hyg. 64, 119\u201324 (2001).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"1070_CR35","doi-asserted-by":"publisher","first-page":"826","DOI":"10.4269\/ajtmh.1994.51.826","volume":"51","author":"EE Zijlstra","year":"1994","unstructured":"Zijlstra, E. E., el-Hassan, A. M., Ismael, A. & Ghalib, H. W. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am. J. Trop. Med Hyg. 51, 826\u2013836 (1994).","journal-title":"Am. J. Trop. Med Hyg."},{"key":"1070_CR36","doi-asserted-by":"publisher","first-page":"e0005527","DOI":"10.1371\/journal.pntd.0005527","volume":"11","author":"M Osman","year":"2017","unstructured":"Osman, M. et al. A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. PLoS Negl. Trop. Dis. 11, e0005527 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1070_CR37","doi-asserted-by":"publisher","first-page":"234ra256","DOI":"10.1126\/scitranslmed.3008222","volume":"6","author":"S Das","year":"2014","unstructured":"Das, S. et al. Modular multiantigen T cell epitope-enriched DNA vaccine against human leishmaniasis. Sci. Transl. Med 6, 234ra256 (2014).","journal-title":"Sci. Transl. Med"},{"key":"1070_CR38","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1016\/j.vaccine.2011.02.096","volume":"29","author":"J Chakravarty","year":"2011","unstructured":"Chakravarty, J. et al. A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis. Vaccine 29, 3531\u20133537 (2011).","journal-title":"Vaccine"},{"key":"1070_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2249.1999.00844.x","volume":"116","author":"A Sassi","year":"1999","unstructured":"Sassi, A. et al. Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clin. Exp. Immunol. 116, 127\u2013132 (1999).","journal-title":"Clin. Exp. Immunol."},{"key":"1070_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/978-1-4939-9210-2_19","volume":"1971","author":"I Chelbi","year":"2019","unstructured":"Chelbi, I. & Zhioua, E. Establishment, Maintenance of Phlebotomus spp. in the Laboratory, and Infection with Leishmania spp. Methods Mol. Biol. 1971, 351\u2013368 (2019).","journal-title":"Methods Mol. Biol."},{"key":"1070_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2022.106303","volume":"228","author":"M Trimeche","year":"2022","unstructured":"Trimeche, M. et al. Effects of multiple feedings on sensitized rabbits on the fitness of Phlebotomus papatasi (Diptera: Psychodidae). Acta Trop. 228, 106303 (2022).","journal-title":"Acta Trop."},{"key":"1070_CR42","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3376\/1081-1710(2007)32[371:EIFTSO]2.0.CO;2","volume":"32","author":"E Zhioua","year":"2007","unstructured":"Zhioua, E., Kaabi, B. & Chelbi, I. Entomological investigations following the spread of visceral leishmaniasis in Tunisia. J. Vector Ecol. 32, 371\u2013374 (2007).","journal-title":"J. Vector Ecol."},{"key":"1070_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2020.105342","volume":"204","author":"W Fares","year":"2020","unstructured":"Fares, W. et al. Co-circulation of Toscana virus and Leishmania infantum in a focus of zoonotic visceral leishmaniasis from Central Tunisia. Acta Trop. 204, 105342 (2020).","journal-title":"Acta Trop."},{"key":"1070_CR44","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/v14050904","volume":"14","author":"K Dachraoui","year":"2022","unstructured":"Dachraoui, K. et al. Transmission dynamics of punique virus in Tunisia. Viruses 14, 904 (2022).","journal-title":"Viruses"},{"key":"1070_CR45","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.vetpar.2014.02.045","volume":"202","author":"I Martin-Martin","year":"2014","unstructured":"Martin-Martin, I. et al. High levels of anti-Phlebotomus perniciosus saliva antibodies in different vertebrate hosts from the re-emerging leishmaniosis focus in Madrid, Spain. Vet. Parasitol. 202, 207\u2013216 (2014).","journal-title":"Vet. Parasitol."},{"key":"1070_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.vetpar.2012.11.002","volume":"192","author":"GD Melo","year":"2013","unstructured":"Melo, G. D. et al. Pro-inflammatory cytokines predominate in the brains of dogs with visceral leishmaniasis: a natural model of neuroinflammation during systemic parasitic infection. Vet. Parasitol. 192, 57\u201366 (2013).","journal-title":"Vet. Parasitol."},{"key":"1070_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0165-2427(03)00049-7","volume":"93","author":"S Fujiwara","year":"2003","unstructured":"Fujiwara, S. et al. Cytokine profiles of peripheral blood mononuclear cells from dogs experimentally sensitized to Japanese cedar pollen. Vet. Immunol. Immunopathol. 93, 9\u201320 (2003).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"1070_CR48","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.vaccine.2010.02.089","volume":"28","author":"J Trigo","year":"2010","unstructured":"Trigo, J. et al. Treatment of canine visceral leishmaniasis by the vaccine Leish-111f+MPL-SE. Vaccine 28, 3333\u20133340 (2010).","journal-title":"Vaccine"},{"key":"1070_CR49","unstructured":"Manfrin, A. & Joshi, M. Vaccine efficacy: The implication of using odds ratio and relative risk for the calculation. Which one would you choose? PharmaScholar (2021)."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01070-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01070-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01070-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T18:54:26Z","timestamp":1739559266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-025-01070-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1038\/s41541-025-01070-8","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"5 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The FDA is currently the owner of two US patents that claim attenuated Leishmania species with the centrin gene deletion (US7,887,812 and US 8,877,213). All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}